Ban M, de Céaurriz J
Institut National de Recherche et de Sécurité, Vandoeuvre, France.
Toxicol Lett. 1988 Jan;40(1):71-6. doi: 10.1016/0378-4274(88)90184-1.
Male Swiss OF1 mice received a single oral dose of either 80 mg/kg hexachloro-1,3-butadiene (HCBD) or 40 mg/kg methyl mercury (MeHg). Examination of cryostat kidney sections stained for alkaline phosphatase (APP) revealed damage to about 50% of the proximal tubules after 8 h. Treatment with the organic anion transport inhibitor probenecid (i.p., 3 x 0.75 mmol/kg) did not have any renal effect in normal mice but reduced the number of damaged tubules by 80 and 90% in mice treated with HCBD and MeHg respectively. The results support the conclusion that the toxicity of HCBD and MeHg to the mouse kidney is related to a probenecid-sensitive transport process. It cannot be stated from the present investigation whether the inhibition nephrotoxicity data are related to classic organic anion secretion by the kidney.
雄性瑞士OF1小鼠单次口服80毫克/千克六氯-1,3-丁二烯(HCBD)或40毫克/千克甲基汞(MeHg)。对用碱性磷酸酶(APP)染色的低温恒温器肾脏切片进行检查发现,8小时后约50%的近端小管受损。用有机阴离子转运抑制剂丙磺舒(腹腔注射,3×0.75毫摩尔/千克)处理对正常小鼠没有任何肾脏影响,但在用HCBD和MeHg处理的小鼠中,受损小管数量分别减少了80%和90%。结果支持以下结论:HCBD和MeHg对小鼠肾脏的毒性与丙磺舒敏感的转运过程有关。从目前的研究中无法确定抑制肾毒性数据是否与肾脏经典的有机阴离子分泌有关。